CDC 42 BIM AND THE OSTEOCLAST
CDC 42 BIM AND THE OSTEOCLAST
批准号:
7729102
负责人:
Steven L Teitelbaum
金额:
$38.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-18 至 2011-08-31
关键词:
AddressAnimalsApoptosisArthritisBone ResorptionCell CountCell ProliferationCell physiologyCellsCytoskeletonDeath RateDiseaseEquilibriumGuanosine Triphosphate PhosphohydrolasesLongevityModelingMonomeric GTP-Binding ProteinsMusOsteoblastsOsteoclastsOsteoporosisPositioning AttributePostmenopausal OsteoporosisProcessProtein IsoformsProteinsRoleSeriesStructureTissuesbasebonebone lossbone masscdc42 GTP-Binding Proteincell typein vivomembernovelpro-apoptotic proteinresearch studyrhorho GTP-Binding Proteinsselective expressiontherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Various members of the Ras superfamily of small GTPases, which comprise over 200 proteins, are expressed selectively in all cells, where they perform a range of cellular functions. A well-studied subfamily is that of the Rho GTPases, with the three best-understood members being Rho, Rac and cdc42. These molecules, including three isoforms of Rac, a number of Rho proteins and cdc42, a single gene product, regulate cell proliferation, differentiation, survival and many aspects of the cytoskeleton. We find cdc42 a particularly important regulator of osteoclast (OC) number and function. While increased cdc42 activity causes
osteoporosis in mice, animals lacking the active GTPase specifically in their OCs have enhanced bone mass. Thus, cdc42 is a candidate therapeutic target for states of accelerated bone resorption. cdc42 deletion in OCs enhances their number by suppressing apoptosis, a process accompanied by increased amounts of the proapoptotic protein Bim. However, the impact of osteoclastic Bim on cell number and resorptive capacity in the context of cdc42 presence or absence is unknown. Moreover, Bim is also expressed in osteoblasts (OBs),
where it regulates their lifespan and function. Finally, while Bim structure/function studies have been performed in a number of cell types, the residues that control OC and OB apoptosis are unknown. Based on these facts we hypothesize that: 1) absence of cdc42 in OCs arrests pathological bone loss; 2) cdc42 and Bim act in concert in OCs to regulate apoptosis of bone resorptive cells, while Bim controls the OB and 3) specific residues in Bim govern its capacity to regulate OC and OB apoptosis. Given that we have generated mice with gain or loss of cdc42 function in OCs and have the capacity to selectively delete Bim in OCs or OBs in vivo, we are positioned to address the following specific aims: 1) determine the role of osteoclastic cdc42 in pathological bone loss, 2) determine how cdc42 and Bim, expressed in OCs and OBs, regulate apoptosis and bone mass in resorptive cells and 3) identify the specific residues in Bim that govern its capacity to regulate OC and OB apoptosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hepatic steatosis promotes liver metastasis
-
批准号:10365691
-
项目类别:
-
资助金额:$45.72万
-
财政年份:2022
-
负责人:Steven L Teitelbaum
-
依托单位:
Hepatic steatosis promotes liver metastasis
-
批准号:10545090
-
项目类别:
-
资助金额:$47.08万
-
财政年份:2022
-
负责人:Steven L Teitelbaum
-
依托单位:
FAT TALKS TO BONE
-
批准号:9978044
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2017
-
负责人:Steven L Teitelbaum
-
依托单位:
FAT TALKS TO BONE
-
批准号:10163838
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2017
-
负责人:Steven L Teitelbaum
-
依托单位:
FAT TALKS TO BONE
-
批准号:9526487
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2017
-
负责人:Steven L Teitelbaum
-
依托单位:
FAT TALKS TO BONE
-
批准号:9754825
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2017
-
负责人:Steven L Teitelbaum
-
依托单位:
Mechanisms of Rankl Mediated Osteoclast Activation
-
批准号:7812306
-
项目类别:
-
资助金额:$43.87万
-
财政年份:2009
-
负责人:Steven L Teitelbaum
-
依托单位:
MECHANISMS OF POLARIZED SECRETION BY BONE CELLS
-
批准号:7858352
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2009
-
负责人:Steven L Teitelbaum
-
依托单位:
MECHANISMS OF POLARIZED SECRETION BY BONE CELLS
-
批准号:7633796
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2009
-
负责人:Steven L Teitelbaum
-
依托单位:
Mechanisms of Polarized Secretion by Bone Cells
-
批准号:8274354
-
项目类别:
-
资助金额:$32.5万
-
财政年份:2009
-
负责人:Steven L Teitelbaum
-
依托单位:
Mechanisms of Polarized Secretion by Bone Cells
-
批准号:8493782
-
项目类别:
-
资助金额:$30.88万
-
财政年份:2009
-
负责人:Steven L Teitelbaum
-
依托单位:
Mechanisms of Polarized Secretion by Bone Cells
-
批准号:8076266
-
项目类别:
-
资助金额:$32.5万
-
财政年份:2009
-
负责人:Steven L Teitelbaum
-
依托单位:
CDC 42 BIM AND THE OSTEOCLAST
-
批准号:7934686
-
项目类别:
-
资助金额:$37.82万
-
财政年份:2009
-
负责人:Steven L Teitelbaum
-
依托单位:
RANK Ligand is a Bone Anabolic Agent
-
批准号:6508327
-
项目类别:
-
资助金额:$34.91万
-
财政年份:2002
-
负责人:Steven L Teitelbaum
-
依托单位:
RANK Ligand is a Bone Anabolic Agent
-
批准号:6933118
-
项目类别:
-
资助金额:$34.23万
-
财政年份:2002
-
负责人:Steven L Teitelbaum
-
依托单位:
RANK Ligand is a Bone Anabolic Agent
-
批准号:7118802
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2002
-
负责人:Steven L Teitelbaum
-
依托单位:
RANK Ligand is a Bone Anabolic Agent
-
批准号:6630326
-
项目类别:
-
资助金额:$37.1万
-
财政年份:2002
-
负责人:Steven L Teitelbaum
-
依托单位:
RANK Ligand is a Bone Anabolic Agent
-
批准号:6792769
-
项目类别:
-
资助金额:$37.1万
-
财政年份:2002
-
负责人:Steven L Teitelbaum
-
依托单位:
MECHANISMS OF AVB3 INTEGRIN MEDIATED BONE RESORPTION
-
批准号:6349974
-
项目类别:
-
资助金额:$30.17万
-
财政年份:2000
-
负责人:Steven L Teitelbaum
-
依托单位:
MECHANISMS OF AVB3 INTEGRIN MEDIATED BONE RESORPTION
-
批准号:6826568
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2000
-
负责人:Steven L Teitelbaum
-
依托单位:
海外基金